Neuronetics Draws Down Remaining $22.5 Million Available Under Credit Facility
03. Oktober 2023 09:21 ET
|
Neuronetics
MALVERN, Pa., Oct. 03, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company with a strategic vision of transforming the lives of patients whenever...
In Recognition of Suicide Prevention Month, NeuroStar Voices Portal Amplifies Stories of Real People Beating Depression
12. September 2023 08:56 ET
|
Neuronetics
MALVERN, Pa., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
NeuroStar Advanced Therapy Wins 2023 dotCOMM Awards
21. August 2023 08:56 ET
|
Neuronetics
MALVERN, Pa., Aug. 21, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
Neuronetics Revolutionizes Patient Communication and Provider Support Through Its Exclusive TrakStar® Platform
14. August 2023 09:02 ET
|
Neuronetics
MALVERN, Pa., Aug. 14, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
Neuronetics Reports Record Second Quarter 2023 Financial and Operating Results
08. August 2023 07:30 ET
|
Neuronetics
MALVERN, Pa., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “Company” or “Neuronetics”) a commercial stage medical technology company with a strategic vision of...
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
04. August 2023 16:30 ET
|
Neuronetics
MALVERN, Pa., Aug. 04, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
Neuronetics to Report Second Quarter 2023 Financial and Operating Results and Host Conference Call
25. Juli 2023 08:30 ET
|
Neuronetics
MALVERN, Pa., July 25, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
Neuronetics Announces Expanded TMS Therapy Access Through Aetna® Health Plans
19. Juli 2023 08:56 ET
|
Neuronetics
MALVERN, Pa., July 19, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
NeuroStar Achieves Milestone Regulatory Clearance in South Korea
17. Juli 2023 08:46 ET
|
Neuronetics
MALVERN, Pa., July 17, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
NeuroStar Advanced Therapy Wins 2023 Bulldog PR Award For Partnership With Drew Robinson, Mental Health Advocate and Former MLB Player
11. Juli 2023 08:56 ET
|
Neuronetics
MALVERN, Pa., July 11, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...